These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 222486)

  • 21. Immune control of SV40-induced tumors in mice.
    Pan S; Abramczuk J; Knowles BB
    Int J Cancer; 1987 Jun; 39(6):722-8. PubMed ID: 3034805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-induced cellular immunity to simian virus 40 tumor-specific surface antigen(s) in adult LVG:LAK hamsters.
    Weppner WA; Coggin JH
    J Natl Cancer Inst; 1980 Apr; 64(4):757-63. PubMed ID: 6245298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular immunity to SV40-induced tumor cells and solubilized tumor-associated antigens in immune mice using an isotopic footpad assay.
    Dean JH; Lewis DD; Padarathsingh ML; McCoy JL; Northing JW; Natori T; Law LW
    Int J Cancer; 1977 Dec; 20(6):951-9. PubMed ID: 201575
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen.
    Knowles BB; Koncar M; Pfizenmaier K; Solter D; Aden DP; Trinchieri G
    J Immunol; 1979 May; 122(5):1798-806. PubMed ID: 87443
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytotoxic T lymphocytes in SV40 infections.
    Schell TD; Tevethia SS
    Methods Mol Biol; 2001; 165():243-56. PubMed ID: 11217391
    [No Abstract]   [Full Text] [Related]  

  • 27. Isolation of a tumor-associated transplantation antigen (TATA) from an SV40-induced sarcoma. Resemblance to the TATA of chemically induced neoplasms.
    DuBois GC; Appella E; Law LW
    Int J Cancer; 1984 Oct; 34(4):561-6. PubMed ID: 6208155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A requirement for three cell types for in vitro generation of specific secondary cell-mediated cytotoxic response against SV40-induced tumor-associated antigens in mice.
    Glaser M
    Cell Immunol; 1980 Feb; 49(2):415-20. PubMed ID: 6243517
    [No Abstract]   [Full Text] [Related]  

  • 29. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
    Gooding LR; Edwards CB
    J Immunol; 1980 Mar; 124(3):1258-62. PubMed ID: 6244348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein).
    Tevethia SS; Flyer DC; Tjian R
    Virology; 1980 Nov; 107(1):13-23. PubMed ID: 6255675
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.
    Bright RK; Beames B; Shearer MH; Kennedy RC
    Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma.
    Rogers MJ; Law LW
    Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo induction of tumor-specific immunity by glycolipid extracts of SV40-transformed cells.
    Ansel S; Blangy D
    Int J Cancer; 1984 Oct; 34(4):555-9. PubMed ID: 6092285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. I. Serological analysis of the antigenic specificities.
    Ting CC; Ortaldo JR; Herberman RB
    Int J Cancer; 1973 Sep; 12(2):511-8. PubMed ID: 4134537
    [No Abstract]   [Full Text] [Related]  

  • 36. Augmentation of specific tumor immunity against a syngeneic SV40-induced sarcoma in mice by retinoic acid.
    Glaser M; Lotan R
    Cell Immunol; 1979 Jun; 45(1):175-81. PubMed ID: 222484
    [No Abstract]   [Full Text] [Related]  

  • 37. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VII. Induction of SV40 TrAg in nonpermissive mouse cells by early viable SV40 deletion (o.54/0.59) mutants.
    Tevethia SS; Flyer DC; Tevethia MJ; Topp WC
    Virology; 1980 Dec; 107(2):488-96. PubMed ID: 6256944
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen.
    Mylin LM; Deckhut AM; Bonneau RH; Kierstead TD; Tevethia MJ; Simmons DT; Tevethi SS
    Virology; 1995 Apr; 208(1):159-72. PubMed ID: 11831696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen.
    Gooding LR; O'Connell KA
    J Immunol; 1983 Nov; 131(5):2580-6. PubMed ID: 6313808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VIII. Retention of SV40 TrAg sites on purified SV40 large T antigen following denaturation with sodium dodecyl sulfate.
    Flyer DC; Tevethia SS
    Virology; 1982 Feb; 117(1):267-70. PubMed ID: 6175086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.